Giant-cell arteritis (GCA) is a chronic vasculitis of the elderly usually involving the ophthalmic arteries, which can result in visual loss. High platelet counts may have some pathogenic significance in the obstruction of the ophthalmic circulation and a few cases of associated essential thrombocythaemia and GCA have been described. Here we report a case of severe temporal arteritis associated with essential thrombocythaemia.
Giant-cell arteritis is a chronic vasculitis of large-sized and medium-sized vessels, histologically characterized by mononuclear-cell infiltrates or granulomatous inflammation, usually including multinucleated giant cells. Although it may be widespread, symptomatic vessel inflammation usually involves the cranial branches of the arteries originating from the aortic arch (I).
Visual loss due to obstruction of the ophthalmic circulation represents a common clinical feature. Vessel occlusion is probably due in part to the thickening of the wall resulting in a narrowed lumen, and in part to intraluminal thrombosis. High platelet counts may have some pathogenic significance in the obstruction of the ophthalmic circulation. Platelet count commonly tends to be increased in GCA, probably because thrombocytes behave as acute-phase reactants in an inflammatory response. A French prospective study suggests a relationship between a platelet count >400xI0 9 /L and an increased risk of permanent visual loss (2), but this finding has not been confirmed by other retrospective cohorts (3) (4) (5) (6) . Moreover, antiplatelet therapy has been advocated as a protective factor for visual loss in giant cell arteritis by some authors (7) (8) , even if most of papers do not confirm these findings (6, (9) (10) .
Myeloproliferative disorders may also result in increased platelet counts. GCA has been reported to be associated with both myeloproliferative and myelodysplastic syndromes (I I). To the best of our knowledge, essential thrombocythaemia has been reported in association with giant cell arteritis in three cases (11-12) and with polymalgia rheumatica in two cases (11). The diagnosis of essential thrombocythaemia was established either before or concomitantly with that of GCA.
Here we report a case of severe temporal arteritis associated with essential thrombocythaemia.
MATERIALS AND METHODS
An 80-year-old man presented to the emergency room at our institution with persistent headache and left-sided visual loss on waking up that morning. The patient had been well until two weeks previously, when he started complaining of a throbbing fronto-temporal headache and jaw claudication. Three days later, he perceived on palpation two symmetrical swollen cords in the temporal regions, followed a few days later by left-sided scalp tenderness. Outpatient serum tests revealed an increased erythrocyte sedimentation rate (104 mm), C-reactive protein (7.44 mg/dl.), platelet count (515 xI0 9/L), and anaemia (haemoglobin 8.8 g/dL).
The patient lived with his wife, had been smoking 20 cigarettes per day for 60 years and did not drink alcohol. His medical history was remarkable for arterial hypertension, chronic obstructive pulmonary disease, severe left carotid stenosis (with a previous episode of transient right brachio-crural paraesthesia and left amaurosis fugax) treated with left endarterectomy two years previously, peripheral obstructive arterial disease, infrarenal aortic aneurysm (diameter 4 em), essential thrombocythaemia diagnosed by bone marrow aspirate two years before, with a platelet count at diagnosis of 1200x 10 9/L and of 500x 10 9/L at last follow-up, mild hyperhomocysteinaemia (heterozygous for both MTHFR C677T and A1298C mutations), localized prostate adenocarcinoma (Gleason score 7) diagnosed four years previously and under treatment with hormonal therapy, and an episode of NSAID-related bleeding duodenal ulcer six years before.
His current medication included amlodipine 5 mg/d, ticlopidine 250 mg/d, hydroxyurea 500 mg/d, calcium folinate 15 mg/d, dutasteride 0.5 mg/d and leuprorelin 3.75 mg/month. He had no known drug allergies.
On admission, he was alert and oriented with normal vital signs (blood pressure 160/70 mmHg; heart rate 75 bpm). Physical examination disclosed pulseless, swollen temporal arteries and frontal bilateral scalp necrosis. Other significant findings included a systolic ejection murmur (4/6) best heard over the aortic area, bilateral carotid bruits, decreased breath sounds bilaterally, vague abdominal tenderness, and weak tibial pulses. The neurological examination was unremarkable, except for left eye blindness. An ophthalmologic examination revealed signs of ischaemic optic neuropathy of the left eye.
RESULTS
Laboratory tests on admission revealed: haemoglobin, 9.5 g/dL mean corpuscular volume 93 mcm'; white cell count, 7.48x 10 9/L (neutrophils 74%); platelet count, 708x 109/L; erythrocyte sedimentation rate 102 mm; C-reactive protein 97.9 mg/dL; fibrinogen 555 mg/dL; total protein 6.2 g/dL; albumin 3.4 g/dL; alphal-globulin 9.3%, alphaz-globulin 18.8%; ferritin 675 ng/mL; serum potassium 3.0 mEq/L. Serum creatinine, glucose, bilirubin, alanine aminotransferase, gamma glutamyl transferase, lactic dehydrogenase, cholesterol, troponin-T levels and urinalysis were within normal limits, as were the prothrombin and partial thromboplastin time. An ECG recorded normal sinus rhythm; echocardiography showed moderate aortic stenosis and left ventricular hypertrophy. A head CT ruled out intracerebral haemorrhage or intracranial hypertension. Bilateral temporal artery duplex exam showed hypoechoic circumferential wall thickening around a narrowed artery lumen, consistent with the "halo sign". A vascular duplex ultrasound study showed normal carotid flow bilaterally and confirmed infrarenal aortic aneurysm (diameter 3 em) and obstruction of the right posterior tibial artery. Cerebral magnetic resonance angiography showed white matter changes consistent with widespread small-vessel disease.
Clinical and laboratory data were sufficiently suggestive for GCA, so temporal artery biopsy was not performed. Therapy with methylprednisolone 60 mg/d i.v., omeprazole 80 mg/d p.o., potassium chloride 1200 mg/d p.o, ramipril 5 mg/d p.o. was started and ticlopidine dosage was increased to 500 mg/d. Over the following days, headache and jaw claudication progressively disappeared, but left eye blindness remained. The patient was discharged on day 18 with normal erythrocyte sedimentation rate and C-reactive protein, and a schedule for gradual reduction ofmethylprednisolone therapy. At the oneyear follow-up visit, the patient's left eye was still blind, but he was otherwise well, without headache or further visual changes, and methylprednisolone had been tapered down to 6 mg/d. Furthermore, he had experienced no more thrombotic events and his platelet count had decreased to 378xl0 9/L.
DISCUSSION
We describe a case of severe temporal arteritis with permanent loss of vision in the left eye. Visual manifestations represent the most. feared aspect of this vasculitis. They occur in about 30% of patients, with permanent loss of vision in 12%-15% (13) . Visual symptoms are usually secondary to anterior ischemic optic neuropathy and less commonly to central retinal artery occlusion (14) . Traditionally, some factors associate with a lower risk ofpermanent visual loss, such as "constitutional" manifestations (asthenia, anorexia, weight loss >5%, temperature >38°C) (2) (3) 5, 15) , elevated liver enzyme levels (15) and anaemia (3) (4) . Instead, risk factors for permanent visual loss include amaurosis fugax (2-3, 5, 15) , transient diplopia (3, 5) and jaw claudication (15) . Some studies (2-4) suggested a protective role of elevated levels of inflammatory markers (erythrocyte sedimentation rate and C-reactive protein), but these data were not confirmed by others (5, 15) . In patients with established visual loss, visual recovery is uncommon despite treatment with high doses of systemic corticosteroids (16) .
Our patient had several additional risk factors for the development of vascular occlusive or thrombotic events which may have contributed to his complications, including heavy smoking habit, hypertension, hyperhomocysteinaemia, cancer and hormonal therapy (17) . Furthermore, he had already undergone carotid endarterectomy for severe symptomatic stenosis. Late presentation, in this case fifteen days after symptom onset, is also a major determinant of lack of visual recovery.
It is possible that in our patient the coexistence of essential thrombocythaemia contributed to the severity of the clinical picture. Because such association has been described so rarely, at the present time it is unclear whether it is coincidental (both diseases have increased incidence in the elderly), if the haematological disorder leads to dysregulation of cellular and humoral immune function which influences . systemic autoimmune manifestations, or, rather more simply, if thrombocythaemia just promotes arterial thrombosis.
In conclusion, we suggest a high index of suspicion for visual complications in patients with temporal arteritis and essential thrombocythaemia, although other studies are necessary to confirm this hypothesis.
